SCHEMBL30207514

SCHEMBL30207514

CC(C)(C)OC(=O)N1CC=C(N2CCN(c3ccc(OCc4ccccc4)cc3F)CC2)C(F)(F)C1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.42
▸ YAP1 P46937 3/20 0.41
▸ GPR119 Q8TDV5 7/20 0.41
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA5A P35218 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA5B Q9Y2D0 1/20 0.40
▸ GHSR Q92847 2/20 0.40
▸ TLR9 Q9NR96 2/20 0.39
▸ TLR7 Q9NYK1 1/20 0.39
▸ KIT P10721 1/20 0.39
▸ FLT3 P36888 1/20 0.39
▸ SLC2A1 P11166 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ TACR1 P25103 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23783422 1.00 GRM5 (0.42) GRM5YAP1GPR119CA12CA1
SCHEMBL8221363 0.85 GPR119 (0.53) GRM5YAP1GPR119CA12CA1
SCHEMBL23783299 0.83 GHSR (0.42) GRM5YAP1GPR119CA12CA1
SCHEMBL27241629 0.82 ACHE (0.43) GPR119KMT2ATACR1
SCHEMBL30032767 0.80 GPR119 (0.46) GRM5YAP1GPR119CA12CA1
SCHEMBL23783155 0.80 GPR119 (0.46) GRM5YAP1GPR119CA12CA1
SCHEMBL30255499 0.78 ALDH1A1 (0.49) KMT2A
SCHEMBL8259695 0.78 GPR119 (0.53) YAP1GPR119CA12CA1CA2
SCHEMBL31306775 0.77 PRMT5 (0.46) YAP1GPR119GHSR
SCHEMBL25846129 0.75 GRM5 (0.40) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119823124-A Compounds for targeted degradation of BRD9 C4医药公司 2025-04-15 — — CN disclosed
CN-115279370-B Compounds for targeted degradation of BRD9 C4医药公司 2025-01-10 — — CN disclosed
EP-4114392-A1 COMPOUNDS FOR TARGETED DEGRADATION OF BRD9 C4 Therapeutics, Inc. (US) 2023-01-11 — — EP disclosed
Send feedback